申请人:U.S. Philips Corporation
公开号:US03937841A1
公开(公告)日:1976-02-10
The invention relates to new compounds of formula I ##SPC1## and salts thereof with pharmaceutically acceptable acids, in which formula all the substituents may be hydrogen, while R.sub.1 and R.sub.2 may furthermore be a methyl group, R.sub.3 an alkyl group, an alkoxy-alkylene group, an alkylthioalkylene group, an alkylsulphoxyalkylene group or an alkylsulphonalkylene group having up to 8 carbon atoms or a benzyl group, and R.sub.4, R.sub.5 and R.sub.6 a halogen atom, an alkyl group, an alkoxy group or an alkylthio group having up to 6 carbon atoms, a benzyloxy group, --OH, --NH.sub.2, a mono- or dialkylamino group, in which the alkyl group(s) contain(s) 1 or 2 carbon atoms, --CN or --CF.sub.3, and two of the substituents R.sub.4, R.sub.5 and R.sub.6 may each represent a metanitro group or together a trimethylene group, a tetramethylene group, a methylene dioxy group, an ethylene dioxy group, a benzo group, a pyridino group, an indeno-1,2-, a 1,4-benzthiazino-2,3 group or a 1,4-benzoxthiino-2,3 group, with the exception of the HCl salt of the compound in which R.sub.5 and R.sub.6 each represent an orthochlorine atom and R.sub. 1, R.sub.2, R.sub.3 and R.sub.4 each represent hydrogen.
该发明涉及化学式I的新化合物及其与药学上可接受的酸盐,其中化合物中的所有取代基可能是氢,而R.sub.1和R.sub.2还可能是甲基基团,R.sub.3是烷基基团、烷氧基-烷基基团、烷基硫基-烷基基团、烷基磺氧基-烷基基团或烷基磺酸基-烷基基团,碳原子数最多为8,或苄基基团,R.sub.4、R.sub.5和R.sub.6是卤素原子、烷基基团、烷氧基或烷基硫基,碳原子数最多为6,苄氧基,-OH,-NH.sub.2,一元或二元烷基胺基团,其中烷基基团包含1或2个碳原子,-CN或-CF.sub.3,其中取代基R.sub.4、R.sub.5和R.sub.6中的两个可以分别表示一个甲基硝基基团,或者一起表示一个三亚甲基基团、四亚甲基基团、亚甲二氧基基团、乙烯二氧基基团、苯基团、吡啶基团、茚-1,2-基团、1,4-苯并噻吩-2,3基团或1,4-苯并噻吩-2,3基团,除了化合物的HCl盐,其中R.sub.5和R.sub.6各代表一个邻氯原子,而R.sub.1、R.sub.2、R.sub.3和R.sub.4各代表氢。